Guillaume Favier PhD
Partner, Healthcare & Life Sciences Strategy and Performance Transformation
KPMG in the UK
Guillaume focuses on commercial and medical strategy, supporting clients throughout the life cycle of their products from pre-launch to launch execution and life cycle management.
He is a research scientist by background and has worked both in academia and in the industry before becoming a consultant. Outside of work, he is a trustee of two charities: patient association Cardiomyopathy UK and the London Gay Symphonic Winds, an amateur LGBTQ+ wind band.
-
PhD in Organic Chemistry (total synthesis of Herbimycin A, a naturally occurring benzoquinone ansamycin antibiotic)
-
MSc in General Chemistry
-
Commercial Strategy
-
Medical Affairs Strategy
-
Portfolio Strategy
-
Market Development Strategy
-
Opportunity Assessment inc. Disease and Therapeutic Area Assessment